News

STAT3 | D. Stoiber-Sakaguchi
Tuesday, 16. July 2024

The protein STAT3 helps the immune system to recognise leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to a study at the Karl Landsteiner University of Health Sciences (KL Krems). The study showed that STAT3 influences the formation of surface structures on leukemic cells that make them vulnerable to the immune system. If these structures are missing, leukemic cells can escape the body's innate immune surveillance. The expression of STAT3 in and the surface structures on leukemic cells could be a potential biomarker for future immunotherapies.

adobestock_306406655_knochenmetastasen_web

Researchers from the Karl Landsteiner University aim to develop a novel model of bone metastatic disease in breast cancer. A new project just launched aims at gaining insights into the development of bone metastases in breast cancer patients and identifying biomarkers as well as new treatment strategies.

glueckliche_frau_women-1898499_pixabay

Major worldwide research project discovers that 71% of women are unhappy with their breast size. The resulting reduced breast awareness might influence cancer detection by self-examination.

foto_abraham_maimonides_lectures_2019

The second event of the Maimonides Lectures in Lower Austria "Psyche. Health, Disease and Healing in the Frame of Reference of the Abrahamic Religions", the 10th of the entire series of Maimonides Lectures scientifically led by Prof. Dr. Patrizia Giampieri-Deutsch and Prof. Dr. Hans-Dieter Klein, took place on Wednesday 27th and Thursday 28th November 2019 in the ballroom of the Karl Landsteiner Private University for Health Sciences in Krems an der Donau.

weihnachtskekse_kl_klein

We would like to take this opportunity to say goodbye to you for the Christmas holidays.

klu_portrait-9_podar_web_klein

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria (KL Krems) participated. The results have now been published in the New England Journal of Medicine. Thanks to a new mode of action, the compound brings hope to the growing number of patients whose tumor cells have become resistant to the three backbone drug classes.

dsc_6056

On Wednesday, 25.9.2019, a delegation of ACMIT - Austrian Center for Medical Innovation and Technology, honoured the Karl Landsteiner University of Health Sciences (KL) during a company outing.

kl_seaman_award_gewinner_innen_16092019_c_klaus_ranger

On Monday, September 16th 2019, the Seaman Award was awarded for the first time to five medical graduates for their outstanding Master's theses at their academic ceremony.

phagen_konferenz_ukstp_12092019_img_9563

On Thursday, September 12, 2019, the closing event of the Life Science project "The role of phage in antibiotic resistance" took place at the University Hospital St. Pölten. During the one-day conference international scientists discussed the results of almost four years of research. Karl Landsteiner University of Health Sciences was part oft he research project.

img_20190708_094834_gedreht

The ESB Conference will take place this year from 7-10 July for the 25th time, the first time in Vienna. The Karl Landsteiner University of Health Sciences is a member of the Organizing Committee together with the Vienna University of Technology and the European Society of Biomechanics. Around 750 participants from more than 30 nations will take part in the conference.

58

At its meeting on 3 July 2019, the KL General Assembly reappointed Rudolf Mallinger as Rector and Sabine Siegl as Prorector for the term of office from 1 February 2020 to 31 January 2026.

dsc_5775_gut

Every two years, all levels of the ÖH are newly elected by the students.

wearable_foto_img_20190423_153602681_c_v.mlakic

Software for an innovative wearable that could optimise the collection of data in psychological studies is being developed by researchers at KL University. The device will be tested on around 150 subjects as part of an investigation entitled ‘Laughter in everyday life’*, a project which is funded by the FWF. The advantage of the wearable – in this case an armband – is that it can be quickly accessed to record data and is simple to operate. These advantages will come into their own in psychological studies that use the experience sampling method, where subjects are required to record everyday experiences. In the past, written records or smartphones have been used for data collection, but this can result in distortion of the findings.

Further information